| |
| |
|
| Insider
Information: |
Polymeropoulos Mihael Hristos |
| Relationship: |
|
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,871,730 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$9,377,367 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,871,730 |
|
|
| Total
Value |
$9,377,367 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
17
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -108.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vanda Pharmaceuticals Inc. |
VNDA |
|
2024-03-05 |
1,871,730 |
2006-11-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
111 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• • – |
2007-08-13 |
4 |
OE |
$0.03 |
$331 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2015-02-05 |
4 |
OE |
$0.03 |
$1,594 |
D/D |
48,154 |
552,018 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• • – |
2006-11-06 |
4 |
OE |
$0.33 |
$5,346 |
D/D |
16,200 |
16,200 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• • – |
2006-11-07 |
4 |
OE |
$0.33 |
$372 |
D/D |
1,127 |
1,127 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• • – |
2006-12-11 |
4 |
OE |
$0.33 |
$49,500 |
D/D |
150,000 |
150,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• – – |
2007-01-16 |
4 |
OE |
$0.33 |
$3,310 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• • – |
2007-02-12 |
4 |
OE |
$0.33 |
$3,310 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• • – |
2007-03-12 |
4 |
OE |
$0.33 |
$3,310 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• • – |
2007-04-16 |
4 |
OE |
$0.33 |
$3,310 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• • – |
2007-05-14 |
4 |
OE |
$0.33 |
$3,310 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• • – |
2007-06-11 |
4/A |
OE |
$0.33 |
$3,310 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• • – |
2007-06-11 |
4 |
OE |
$0.33 |
$3,310 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• • – |
2007-07-16 |
4 |
OE |
$0.33 |
$3,310 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2015-05-21 |
4 |
OE |
$0.33 |
$11,852 |
D/D |
35,806 |
584,727 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2015-05-22 |
4 |
OE |
$0.33 |
$119,099 |
D/D |
359,815 |
927,385 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• • – |
2008-08-07 |
4 |
B |
$1.00 |
$182,372 |
D/D |
182,000 |
182,000 |
2.81 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• • – |
2008-08-20 |
4 |
B |
$1.12 |
$56,746 |
D/D |
50,000 |
350,000 |
2.81 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• • – |
2008-08-11 |
4 |
B |
$1.13 |
$134,917 |
D/D |
118,000 |
300,000 |
2.81 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2022-12-05 |
4 |
OE |
$3.12 |
$232,861 |
D/D |
74,635 |
1,427,401 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2022-12-06 |
4 |
OE |
$3.12 |
$235,139 |
D/D |
75,365 |
1,455,116 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2013-02-14 |
4 |
D |
$3.95 |
$66,502 |
D/D |
(16,836) |
455,564 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2024-03-05 |
4 |
S |
$4.13 |
$100,273 |
D/D |
(24,288) |
1,871,730 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2024-03-04 |
4 |
S |
$4.24 |
$131,066 |
D/D |
(30,884) |
1,896,018 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2012-02-16 |
4 |
S |
$4.69 |
$53,254 |
D/D |
(11,350) |
428,650 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2015-09-09 |
4 |
OE |
$4.73 |
$202,193 |
D/D |
42,747 |
800,894 |
0 |
- |
|
111 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
